Trulance generic availability?

When might Trulance become available as a generic?

The patent for Trulance (plecanatide) is set to expire in 2034 [1]. This expiration date dictates when generic versions could legally enter the market.

What is Trulance used for?

Trulance is prescribed for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IIC) in adults [1].

How does Trulance work?

Trulance is a guanylate cyclase-C (GC-C) agonist. It activates the GC-C receptor in the intestinal epithelium. This activation increases intestinal fluid secretion and motility, which helps to soften stool and promote bowel movements [1].

Are there any active patent challenges for Trulance?

Information regarding active patent challenges for Trulance is not available in the provided text.

Can biosimilars enter the market before patent expiry?

For small molecule drugs like Trulance, the term "biosimilar" is not applicable. Instead, generic versions are developed. Generic drug availability is typically tied to patent expiration dates, with potential for earlier market entry in specific legal circumstances, though details for Trulance are not specified.

What other treatments are available for constipation?

Other treatments for chronic idiopathic constipation and IBS-C include lifestyle changes such as dietary adjustments and increased physical activity, as well as various prescription and over-the-counter medications. These may include osmotic laxatives, stimulant laxatives, and other classes of drugs targeting different mechanisms of action.

Sources:
[1] https://www.drugpatentwatch.com/drug/plecanatide